Come up with a name for your new list and we'll add to it:
NanoValent Pharmaceuticals raised a round of funding on November 03, 2011. Investors include
National Science Foundation.
NanoValent Pharmaceuticals, founded in 2010, is a privately-held company focused on the development and commercialization of a new generation, nanoparticle based, antibody-drug conjugate (ADC) technol…